Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

535.60INR
19 Oct 2017
Change (% chg)

Rs-4.75 (-0.88%)
Prev Close
Rs540.35
Open
Rs541.00
Day's High
Rs543.65
Day's Low
Rs532.00
Volume
62,070
Avg. Vol
477,395
52-wk High
Rs759.00
52-wk Low
Rs433.15

Latest Key Developments (Source: Significant Developments)

Hunan China Sun Pharma Machinery unit signs partnership framework agreement on gene detection project
Thursday, 20 Apr 2017 10:08pm EDT 

April 21(Reuters) - Hunan China Sun Pharma Machinery Co Ltd <300216.SZ> ::* Says its unit signed a partnership framework agreement with Changsha county local health bureau, to provide service for gene detection project for hypertensive patients .  Full Article

Hunan China Sun Pharma Machinery to pay annual cash div as 0.6 yuan per 10 shares for FY 2016
Wednesday, 19 Apr 2017 02:42am EDT 

April 19(Reuters) - Hunan China Sun Pharma Machinery Co Ltd <300216.SZ> : :* Says it plans to pay annual cash dividend as 0.6 yuan(pre-tax) per 10 shares as FY 2016 div payment.  Full Article

Hunan China Sun Pharma Machinery sees Q1 FY 2017 net profit up 0 to 30 pct
Tuesday, 11 Apr 2017 01:30am EDT 

Hunan China Sun Pharma Machinery Co Ltd <300216.SZ> : Sees Q1 FY 2017 net profit to increase by 0 to 30 percent, or to be 18.6 million yuan to 24.2 million yuan . Says Q1 FY 2016 net profit was 18.6 million yuan .The reason for the forecast is increased income of intelligent hybrid packing automatic production line.  Full Article

Beijing Science Sun Pharmaceutical sees FY 2017 Q1 net profit to decrease by 5 pct to 25 pct
Monday, 10 Apr 2017 02:30am EDT 

Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ> : Sees net profit for FY 2017 Q1 to decrease by 5 percent to 25 percent, or to be 44.1 million yuan to 61.8 million yuan, compared to net profit of FY 2016 Q1 (58.9 million yuan) .Says industry circulation policy as main reason for the forecast.  Full Article

Almirall says regulatory filing for Tildrakizumab in Europe is validated
Friday, 24 Mar 2017 02:57am EDT 

Almirall SA :The company and Sun Pharma announce validation of regulatory filing for Tildrakizumab, an antibody designed for treatment of moderate-to-severe plaque psoriasis, by the European Medicines Agency (EMA).  Full Article

Sun Pharma says filing of tildrakizumab with European Medicines Agency by Almirall
Friday, 24 Mar 2017 12:53am EDT 

Sun Pharmaceutical Industries Ltd : Says validation of regulatory filing of tildrakizumab with the european medicines agency (EMA) by Almirall. . Tildrakizumab is an investigational IL-23P19 inhibitor being evaluated for the treatment of moderate-to-severe plaque psoriasis. .Filing includes efficacy, safety data from pivotal phase III clinical trials that included over 1,800 patients.  Full Article

Sun Pharma Industries says Canadian unit to acquire Thallion Pharma
Friday, 17 Mar 2017 05:41am EDT 

Sun Pharmaceutical Industries Ltd : Says deal for c$2.3 million . Taro Pharmaceuticals Inc. (Canada) entered into deal to acquire all issued and outstanding shares of Thallion Pharma . Consideration would be in cash . Post deal, no turnover expected of existing products as all revenue-producing assets have been transferred from Thallion to Bellus Health . Post acquisition of Thallion, Taro Pharma would have only rights for development of orphan drug candidate, Shigamab .No material effect of acquisition by Taro Pharmaceuticals (Canada) on consol revenue, expenses or profits of co.  Full Article

Sun Pharmaceutical Industries says USFDA will lift import alert on Mohali manufacturing facility
Tuesday, 14 Mar 2017 04:22am EDT 

Sun Pharmaceutical Industries Ltd : Says USFDA will lift the import alert imposed on the Mohali (Punjab) manufacturing facility .Says USFDA will remove Mohali facility from the official action initiated status.  Full Article

Sun Pharmaceutical Industries says European Medicines Agency approves Tobramycin
Thursday, 16 Feb 2017 04:29am EST 

Sun Pharmaceutical Industries Ltd : Sun Pharmaceutical Industries clarifies on news item "UK regulator approves Sun Pharma generic drug of Tobramycin" .Approval for product, is not from UK regulator but from European Medicines Agency.  Full Article

Sun Pharma to buy Novartis' cancer drug Odomzo
Wednesday, 21 Dec 2016 10:01pm EST 

Sun Pharmaceutical Industries Ltd : Says Sun Pharma to acquire branded oncology product Odomzo for global markets . Says acquisition of Odomzo from Novartis . Says greement has been signed for an upfront payment of US$ 175 million and additional milestone payments. .says Odomzo is used for treatment of adult patients with labcc that has recurred following surgery or radiation therapy.  Full Article

BRIEF-Sun Pharmaceutical Industries says unit raises shareholding in Ranbaxy Malaysia Sdn Bhd

* Unit agreed to increase shareholding in Ranbaxy Malaysia Sdn Bhd via purchase of 666,985 shares of Ranbaxy Malaysia Source text - http://bit.ly/2g5YoTO Further company coverage: